Mutations within FGFR1 are associated with superior outcome in a series of 83 diffuse midline gliomas with H3F3A K27M mutations

Acta Neuropathol. 2021 Feb;141(2):323-325. doi: 10.1007/s00401-020-02259-y. Epub 2021 Jan 12.

Ulrich Schüller^{1

2

3}, Peter Iglauer⁴, Mario M Dorostkar^{5

6}, Christian Mawrin⁷, Jochen Herms^{5

6}, Armin Giese⁵, Markus Glatzel⁸, Julia E Neumann⁹

¹ Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. [email protected].
² Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. [email protected].
³ Research Institute Children's Cancer Center Hamburg, Hamburg, Germany. [email protected].
⁴ Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
⁵ Center for Neuropathology, Ludwig-Maximilians-University, Munich, Germany.
⁶ German Center for Neurodegenerative Diseases, Munich, Germany.
⁷ Institute of Neuropathology, University Hospital Magdeburg, Magdeburg, Germany.
⁸ Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
⁹ Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. [email protected].

No abstract available

Publication types